ASX - By Stock
|
BDX |
Re:
Ann: Corporate Presentation
|
|
brrrattt
|
37 |
8.7K |
0 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
37
|
8.7K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Chairman and CEO Presentation
|
|
brrrattt
|
22 |
3.9K |
0 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
22
|
3.9K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
brrrattt
|
35 |
7.0K |
2 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
35
|
7.0K
|
2
|
|
ASX - By Stock
|
COV |
Re:
Ann: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
|
|
brrrattt
|
25 |
3.1K |
8 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
25
|
3.1K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
An opportunity to be CEO or remain a non executive director
|
|
brrrattt
|
9 |
1.7K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
9
|
1.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
brrrattt
|
43 |
9.4K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
43
|
9.4K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Enrollment in Phase 3 Clinical Program
|
|
brrrattt
|
19 |
4.1K |
6 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
19
|
4.1K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Enrollment in Phase 3 Clinical Program
|
|
brrrattt
|
19 |
4.1K |
7 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
19
|
4.1K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
brrrattt
|
111 |
23K |
6 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
111
|
23K
|
6
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Trading Halt
|
|
brrrattt
|
17 |
3.2K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
17
|
3.2K
|
2
|
|
ASX - By Stock
|
LIS |
Re:
charts
|
|
brrrattt
|
257 |
122K |
4 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
257
|
122K
|
4
|
|
ASX - By Stock
|
PPK |
Re:
FRIENDLYDWARVES CHANGES SENTIMENT TO BUY
|
|
brrrattt
|
8 |
1.7K |
2 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
8
|
1.7K
|
2
|
|
ASX - By Stock
|
PPK |
Re:
FRIENDLYDWARVES CHANGES SENTIMENT TO BUY
|
|
brrrattt
|
8 |
1.7K |
1 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
8
|
1.7K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
brrrattt
|
21K |
7.1M |
17 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
21K
|
7.1M
|
17
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
brrrattt
|
234 |
58K |
8 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
234
|
58K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
brrrattt
|
234 |
58K |
16 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
234
|
58K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
brrrattt
|
234 |
58K |
7 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
234
|
58K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
brrrattt
|
234 |
58K |
16 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
234
|
58K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
brrrattt
|
234 |
58K |
5 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
234
|
58K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
brrrattt
|
234 |
58K |
0 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
234
|
58K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
brrrattt
|
234 |
58K |
4 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
234
|
58K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
brrrattt
|
234 |
58K |
6 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
234
|
58K
|
6
|
|
ASX - By Stock
|
PPK |
Re:
Ann: CIB announces $30m order
|
|
brrrattt
|
136 |
33K |
2 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
136
|
33K
|
2
|
|
ASX - By Stock
|
PPK |
Re:
Ann: CIB announces $30m order
|
|
brrrattt
|
136 |
33K |
3 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
136
|
33K
|
3
|
|
ASX - By Stock
|
HIQ |
Re:
Ann: Mar24 Quarterly Activities Statement and Appendix 4C
|
|
brrrattt
|
5 |
1.4K |
2 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
5
|
1.4K
|
2
|
|
ASX - By Stock
|
SOM |
Re:
Ann: Appointment of Co-CEO's
|
|
brrrattt
|
23 |
6.4K |
0 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
23
|
6.4K
|
0
|
|
ASX - By Stock
|
SOM |
Re:
Ann: Appointment of Co-CEO's
|
|
brrrattt
|
23 |
6.4K |
0 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
23
|
6.4K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
brrrattt
|
147 |
35K |
1 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
147
|
35K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
brrrattt
|
147 |
35K |
1 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
147
|
35K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: ARG-007 Reduces Effects of TBI in Preclinical Study
|
|
brrrattt
|
16 |
5.4K |
11 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
16
|
5.4K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
brrrattt
|
147 |
35K |
1 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
147
|
35K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
brrrattt
|
147 |
35K |
9 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
147
|
35K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
brrrattt
|
147 |
35K |
8 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
147
|
35K
|
8
|
|
ASX - By Stock
|
LIS |
Re:
charts
|
|
brrrattt
|
257 |
122K |
12 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
257
|
122K
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
brrrattt
|
21K |
7.1M |
31 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
21K
|
7.1M
|
31
|
|
ASX - By Stock
|
LIS |
Re:
Competition
|
|
brrrattt
|
2 |
756 |
8 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
2
|
756
|
8
|
|
ASX - By Stock
|
PPK |
Re:
Ann: CIB announces $30m order
|
|
brrrattt
|
136 |
33K |
2 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
136
|
33K
|
2
|
|
ASX - By Stock
|
PPK |
Re:
Ann: CIB announces $30m order
|
|
brrrattt
|
136 |
33K |
1 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
136
|
33K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
brrrattt
|
234 |
58K |
53 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
234
|
58K
|
53
|
|
ASX - By Stock
|
PPK |
Re:
Ann: CIB announces $30m order
|
|
brrrattt
|
136 |
33K |
8 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
136
|
33K
|
8
|
|
ASX - By Stock
|
PPK |
Re:
Ann: CIB announces $30m order
|
|
brrrattt
|
136 |
33K |
0 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
136
|
33K
|
0
|
|
ASX - By Stock
|
PPK |
Re:
Ann: CIB announces $30m order
|
|
brrrattt
|
136 |
33K |
2 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
136
|
33K
|
2
|
|
ASX - By Stock
|
PPK |
Re:
Ann: CIB announces $30m order
|
|
brrrattt
|
136 |
33K |
3 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
136
|
33K
|
3
|
|
ASX - By Stock
|
ATG |
Re:
Ann: 1HFY24 Investor Presentation
|
|
brrrattt
|
19 |
10K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
19
|
10K
|
0
|
|
ASX - By Stock
|
BMT |
Re:
Ann: Q3 FY24 Trading Update
|
|
brrrattt
|
29 |
6.5K |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
29
|
6.5K
|
2
|
|
ASX - By Stock
|
PTM |
Re:
Ann: Funds Under Management - April 2024
|
|
brrrattt
|
27 |
9.8K |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
27
|
9.8K
|
2
|
|
ASX - By Stock
|
PPK |
Re:
Ann: CIB announces $30m order
|
|
brrrattt
|
136 |
33K |
4 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
136
|
33K
|
4
|
|
ASX - By Stock
|
BMT |
Re:
Ann: Board Chair increases interest in Beamtree to 10.65%
|
|
brrrattt
|
6 |
1.6K |
0 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
6
|
1.6K
|
0
|
|
ASX - By Stock
|
PPK |
Re:
Ann: CIB announces $30m order
|
|
brrrattt
|
136 |
33K |
2 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
136
|
33K
|
2
|
|
ASX - By Stock
|
PPK |
Re:
Ann: CIB announces $30m order
|
|
brrrattt
|
136 |
33K |
0 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
136
|
33K
|
0
|
|